SI-BONE, Inc.
SIBN
Rank in Stocks
#8093
SI-BONE, Inc. is a medical technology company that develops and markets... SI-BONE, Inc. is a medical technology company that develops and markets specialized implantable solutions for musculoskeletal conditions affecting the sacropelvic region. These devices are utilized across the United States and internationally. Its flagship product, iFuse, is a minimally invasive surgical implant system designed to address a range of indications, including sacroiliac joint dysfunction and degeneration, adult spinal deformities, and traumatic fractures of the pelvic ring. Beyond iFuse, the company offers advanced iterations like iFuse-3D. This titanium implant retains the distinctive triangular cross-section of the original iFuse but incorporates a proprietary 3D-printed porous surface and a fenestrated design. Another offering is iFuse-TORQ, a series of 3D-printed threaded implants. These are specifically engineered for treating pelvic fractures and facilitating minimally invasive sacroiliac joint fusion procedures. SI-BONE distributes its products primarily through a dedicated direct sales force, complemented by a network of independent distributors. Established in 2008, the company maintains its corporate headquarters in Santa Clara, California.
Share Price
$25.60
Last synced: 2026-11-09
Market Cap
$1.15B
Change (1 day)
5.61%
Change (1 year)
42.22%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade SI-BONE, Inc. (SIBN)
Category
Healthcare
Operating Margin for SI-BONE, Inc. (SIBN)
Operating Margin as of November 2026 TTM: -8.31%
According to SI-BONE, Inc.'s latest financial reports, its current operating margin (TTM) is -8.31%. At the end of 2025 the company had an operating margin of -11.11%.
Operating Margin history for SI-BONE, Inc. from 2012 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -8.31% | -25.20% |
| 2025 | -11.11% | -47.30% |
| 2024 | -21.08% | -37.61% |
| 2023 | -33.79% | -39.68% |
| 2022 | -56.02% | -2.25% |
| 2021 | -57.31% | 9.06% |
| 2020 | -52.55% | -1.78% |
| 2019 | -53.50% | 147.57% |
| 2018 | -21.61% | -40.24% |
| 2017 | -36.16% | -13.33% |
| 2016 | -41.72% | -35.00% |
| 2015 | -64.18% | -2.25% |
| 2014 | -65.66% | 507.40% |
| 2013 | -10.81% | -62.67% |
| 2012 | -28.96% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 15.24% | -101.83% |
US
|
|
| 18.08% | -102.18% |
IE
|
|
| 21.25% | -102.56% |
US
|
|
| 21.05% | -102.53% |
US
|
|
| 28.09% | -103.38% |
US
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about SI-BONE, Inc.'s operating margin
What is SI-BONE, Inc.'s operating margin?
SI-BONE, Inc.'s operating margin is -8.31%, as of Nov 2026.
What was SI-BONE, Inc.'s operating margin in 2025?
In 2025, SI-BONE, Inc.'s operating margin was -11.11%, compared with -21.08% in 2024.
How has SI-BONE, Inc.'s operating margin changed since 2020?
From 2020 to 2025, SI-BONE, Inc.'s operating margin was highest in 2025 (-11.11%) and lowest in 2021 (-57.31%).
How does SI-BONE, Inc.'s operating margin compare with similar companies?
SI-BONE, Inc.'s operating margin (-8.31%) is lower than that of all 5 similar companies listed above. The highest among them is Edwards Lifesciences Corporation, with 28.09%.